2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration; Wet Age-related Macular Degeneration (wAMD)Not yet recruitingEarly phase 12025-03-21NCT06888492
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular DegenerationNeovascular Age-related Macular DegenerationActive, not recruitingPhase 32025-01-07NCT05461339